RogerVLGoASLloyd-JonesDMAdamsRJBerryJDBrownTM, Heart disease and stroke statistics—2011 update: A report from the American Heart Association. Circulation2011; 123:e18–209.
SmithSCJrAllenJBlairSNBonowROBrassLMFonarowGC, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation2006; 113:2363–72.
FriedenTRBerwickDM. The “Million Hearts™” initiative—preventing heart attacks and strokes. N Engl J Med2011; 365:e27.
8.
GibersonSYoderSLeeMP. Improving patient and health system outcomes through advanced pharmacy practice: A report to the U.S.Surgeon General2011. Washington: Public Health Service (US), Office of the Chief Pharmacist; 2011.
9.
MachadoMBajcarJGuzzoGCEinarsonTR. Sensitivity of patient outcomes to pharmacist interventions. Part I: Systematic review and meta-analysis in diabetes management. Ann Pharmacother2007; 41:1569–82.
10.
MachadoMBajcarJGuzzoGCEinarsonTR. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother2007; 41:1770–81.
11.
MachadoMNassorNBajcarJMGuzzoGCEinarsonTR. Sensitivity of patient outcomes to pharmacist interventions. Part III: Systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother2008; 42:1195–207.
12.
BeneyJBeroLABondC. Expanding the roles of outpatient pharmacists: Effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev 2000(3):CD000336.
13.
Chisholm-BurnsMAKimLee JSpiveyCASlackMHerrierRNHall-LipsyE, US pharmacists’ effect as team members on patient care: Systematic review and meta-analyses. Med Care2010; 48:923–33.
14.
DoucetteWRMcDonoughRP. Beyond the 4Ps: Using relationship marketing to build value and demand for pharmacy services. J Am Pharm Assoc (Wash)2002; 42:183–93.